Published June 2023 | Version v1
Poster Open

B1MG ESHG 2023 poster - A Maturity Level Model (MLM) for the self assessment of genomic medicine practices in healthcare systems

  • 1. ROR icon National Institute of Health Dr. Ricardo Jorge
  • 2. Instituto de Saúde Ambiental da Faculdade de Medicina da Universidade de Lisboa
  • 3. ELIXIR Hub
  • 4. ROR icon University of Luxembourg
  • 5. EATRIS
  • 6. ROR icon Lygature
  • 7. ROR icon Sciensano (Belgium)
  • 8. Danish National Genome Centre
  • 9. ROR icon CSC - IT Center for Science (Finland)
  • 10. Health Service Executive Dublin
  • 11. Health Service Executive Dublin
  • 12. Ministry of Health Italy
  • 13. ROR icon Sapienza University of Rome
  • 14. Ministry of Health, Lithuania
  • 15. ROR icon Vilnius University Hospital Santariskiu Klinikos
  • 16. ROR icon Instituto de Salud Carlos III
  • 17. Ministry of Health, Spain
  • 18. ROR icon Universidade de Santiago de Compostela
  • 19. ROR icon Karolinska University Hospital
  • 20. CERPOP, Université Toulouse III
  • 21. Tervise Arengu Instituut
  • 22. National Genome Centre Denmark
  • 23. Institut de Cancérologie Gustave Roussy
  • 24. EMBL-EBI
  • 25. ROR icon Iscte – Instituto Universitário de Lisboa
  • 26. ROR icon Latvian Biomedical Research and Study Centre
  • 27. Centre for Molecular Medicine Norway (NCMM)
  • 28. ROR icon Murdoch Children's Research Institute
  • 29. ROR icon PHG Foundation
  • 30. ROR icon Queen Mary University of London
  • 31. Pihanet Consulting, Helsinki

Description

Genomic medicine implementation in healthcare systems can bring us one step closer to making personalised medicine a reality with major socioeconomic benefits Citizens and patients can nowadays widely benefit from genomic data analysis for accurate and timely diagnosis, effective treatments with less adverse events, and accurate profiling for disease prevention

 

Implementation of genomics in healthcare is complex, and requires adjustments in the governance, structure and organization of health services, as well as dedicated investments Implementation is also dependent on the country context

 

In the context of the 1 +Million Genomes 1 + initiative, we developed a Maturity Level Model ( for health systems to self evaluate the maturity of their genomic medicine

practices, and define a path to optimization a MLM is tool for healthcare systems to self evaluate the level of maturity of their genomic medicine practices according to a common matrix,and to define a path to optimization

 

A MLM pilot in eight European countries provided important information regarding common strengths, weaknesses and asymmetries across Europe

Files

ESHG 23_Poster MLM_Final.pdf

Files (901.3 kB)

Name Size Download all
md5:cfdd16dd714d71d28094160fbcfcdb7c
901.3 kB Preview Download

Additional details

Funding

European Commission
B1MG - Beyond 1M Genomes 951724

Dates

Other
2023-06-10